Covid-19 roundup: Cure­Vac ex­pands cache to $1.3B as coro­n­avirus race heats up; Russ­ian sci­en­tists pub­lish ear­ly da­ta to back up vac­cine

The mon­ey just keeps on pour­ing in for Cure­Vac.

Fol­low­ing a se­ries of high-pro­file deals and an IPO raise to­tal­ing near­ly $1 bil­lion in re­cent weeks, the biotech an­nounced an­oth­er cash in­jec­tion Fri­day, net­ting about $300 mil­lion (€252 mil­lion) from the Ger­man gov­ern­ment to sup­port its mR­NA Covid-19 vac­cine can­di­date. In ad­di­tion to de­vel­op­ing the vac­cine, the mon­ey will be used to rapid­ly ramp up pro­duc­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER